HTBD Home Page

Home

Market Research to
Gain the Competitive Edge

Customer Loyalty

Designed to help our clients attract and retain loyal customers, the High Tech Business Decisions Customer Loyalty Program includes assessments of customer satisfaction and loyalty, performance ratings and comparisons to competitors, and discernment of current customers' future plans.

>> GO

Industry Insights

The following directories of leading edge suppliers are provided as a courtesy.

>> Biopharmaceutical Contract Manufacturers

>> Fill-and-Finish Contract Manufacturers

>> High Throughput Screening for Drug Discovery Suppliers

"With expertise in complex pharmaceutical drug discovery, biomanufacturing, and electronics manufacturing technologies, our highly trained analysts investigate markets for high tech business-to-business products and services. Our custom reports are in-depth analyses that bring leading edge science together with profitable business strategies for the pharmaceutical and electronics industries." William P. Downey, President

New Report Just Published, October 2011

Biopharmaceutical Contract Manufacturing 2011:
New Participants, Expanded Services and Emerging Markets

This 900-page report provides the latest information about the supply and demand for the outsource production of large-molecule API. This report analyzes the biotechnology industry's biomanufacturing strategies, budgets, contractor relationships and new projects. This report also provides detailed analyses of contractor capacity, current and projected utilization rates, and the adoption of disruptive manufacturing technologies. The data and the analysis in this report are based on 70 in-depth interviews conducted by Ph.D.-level analysts with both executives at biopharmaceutical and contractor companies worldwide. The analyses of their perspectives and insights allow readers to gain an understanding of the market and its future direction. This report includes 235 summary data tables and charts, and is the most comprehensive and current industry report on biopharmaceutical contract manufacturing. Published October 2011.

>> Details & Order

Directory of Biopharmaceutical Contract Manufacturers

The 2011 directory provides a thorough listing of 77 contractors worldwide, including service offerings, equipment, capacity, cGMP status, and other important details

>> Details & Order

Published Reports

Biopharmaceutical Contract Manufacturing:
Best Practices Pricing Study 2011

This 300-page report documents pricing practices, policies, agreements, and strategies for both pharmaceutical and biotechnology companies and contract manufacturers. Learn about industry prices paid to contractors for mammalian cell culture and microbial fermentation production. This report provides batch, time-in-facility, and gram prices. In this report, contract manufacturing prices are analyzed by technology and tank sizes. This report includes both prices paid by users and prices charged by CMOs for contract services. In addition, this report provides extensive information from industry executives on difficult-to-negotiate issues such as liability for failed batches, down payments, cancellation fees, technology transfer fees, process development fees, and more. Published January 2011.

>> Details & Order

Biopharmaceutical Fill-and-Finish: Best Practices Study 2010

This 515-page report, the comprehensive 2010 industry study, provides the latest information on biomanufacturing fill-and-finish strategies, manufacturing technologies, markets, outsourcing, capacity and demand, contractor relationships, pricing policies and practices, prices paid and charged, and future trends in fill-and-finish contract manufacturing industry including growth opportunities and challenges. The data and the analysis in this report are based on 41 in-depth interviews conducted with biomanufacturing directors at pharmaceutical and biotechnology companies and fill-and-finish contractor companies worldwide. The analysis of these perspectives and insights allow readers to make the most successful strategic decisions. This report includes over 180 summary data tables and charts, and is the most comprehensive and current industry report on biopharmaceutical fill-and-finish contract manufacturing. Published September 2010.

>> Details & Order

Directory of Biopharmaceutical Fill-and-Finish Contract Manufacturers

This 2010 directory provides a thorough listing of 34 biopharmaceutical fill-and-finish contractors worldwide, including information on type of services offered, equipment capacity, cGMP certification by service category and more.

>> Details & Order

High Throughput Screening 2010:
Effective Strategies, Innovative Technologies, and Use of Better Assays

This 1050-page report, with over 300 charts and tables, documents current HTS practices for drug discovery and the evolving role of the HTS laboratory in biotech and pharmaceutical companies, academic centers, and institutes worldwide. The study provides an in-depth analysis of the new HTS strategies to increase success, current and expected use of cell-based assays and high content screening, equipment used, targets and target classes growing in importance, types of assays used and new trends, role of primary/stem cells, throughput, the number of compounds screened, microplates, budgets and expenditures by product category, outsourcing trend, market size and growth, unmet needs in HTS, and the challenges and opportunities in HTS for both users and their suppliers. Published February 2010.

>> Details & Order

The History of High Throughput Screening for Drug Discovery:
1998-2005

HighTech Business Decisions (HTBD) has conducted six market research studies and published six comprehensive industry reports on high throughput screening (HTS) since 1998. This report is specifically designed to understand the changes that have occurred in HTS since 1998, how accurate HTS directors have been in forecasting and predicting their use of technology and future needs, how HTS practices have evolved, and the success of HTS as a drug discovery tool. Topics include the number of disease targets screened, target types, assay types, detection modes, microplate formats, outsourcing, and other issues impacting HTS operations and success. The complete analysis, based on both user and supplier primary research, includes market size and growth, major players, user strategies and requirements, documentation of success in drug discovery, trends and technologies, and respondents’ perceptions regarding the future of HTS.

>> Details & Order

info@HighTechDecisions.com